Cellogen Therapeutics raises $2.3M (India, May 2026)
$2.3M
Rs 20 croreGenerated social card
Headline
Cellogen Therapeutics raises Rs 20 crore from Kotak Alts to advance CAR-T cancer therapies - Indian Startup News
About
Cellogen Therapeutics is an Indian biotech startup that develops cell and gene therapies using Chimeric Antigen Receptor T-cell (CAR-T) technology to treat cancers and blood disorders. The company aims to make advanced therapies more accessible and affordable, addressing the high costs associated with existing CAR-T treatments.
Article summary
Cellogen Therapeutics raises Rs 20 crore from Kotak Alts to advance CAR-T cancer therapies Indian Startup News
Founder
Gaurav Kharya
Co-Founder
Investors · 1
Kotak Alternate Asset ManagersLead
FUND
Related rounds
| May 24, 2026 | Paytm | — | — | India |
| May 23, 2026 | SolarSquare | $60.0M | Series C | India |
| May 23, 2026 | Damroo | $60K | — | India |
| May 23, 2026 | Snabbit | $56.0M | Series D | India |